The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)
Kaposi's disease is a multifocal disease with cutaneous expression in more than 95% of cases. There are 4 forms : Mediterranean, Endemic (Sub-Saharan Africa), iatrogenic and epidemic (HIV) The physiological hypotheses to explain the disease are not clear. A proliferation of immunity cells in blood vessels and also an undetermined role of the human herpes virus 8 (HHV-8) could be involved. The treatment is complex and not standardized. There are a lot of different treatments. The purpose of this study is to evaluate the prevalence and described the characteristics and the treatment of the Kaposi's disease in the France's southeast on 10 years, from 2007 to 2017.
Study Type
OBSERVATIONAL
Enrollment
100
Centre Antoine Lacassagne
Nice, Alpes-Maritimes, France
CHU Nice
Nice, Alpes-Maritimes, France
HIA Laveran
Marseille, Bouche Du Rhone, France
CHI de Fréjus
Fréjus, Var, France
Hôpital d'Instruction des Armées Sainte-Anne
Prevalence of Kaposi's disease
Diagnosed patients with biopsy, in France's southeast
Time frame: 10 years (2007-2017)
Descriptive analysis of the different form of the Kaposi's disease in the population
Mediterranean form, endemic form, iatrogenic form and epidemic form
Time frame: 10 years (2007-2017)
Descriptive analysis of the population : sociodemographic
sociodemographic characteristics
Time frame: 10 years (2007-2017)
Descriptive analysis of the population : paraclinical
paraclinical characteristics
Time frame: 10 years (2007-2017)
Descriptive analysis of the population : clinical
clinical characteristics
Time frame: 10 years (2007-2017)
Descriptive analysis of the population : therapeutic
therapeutic care
Time frame: 10 years (2007-2017)
Survival analysis
mortality rate
Time frame: 10 years (2007-2017)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Toulon, Var, France